Literature DB >> 1971830

Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat.

R Kannan1, J F Kuhlenkamp, E Jeandidier, H Trinh, M Ookhtens, N Kaplowitz.   

Abstract

Information on the origin of brain glutathione and the possibility of its transport from blood to brain is limited. We found a substantial uptake of 35S-labeled glutathione by the rat brain using the carotid artery injection technique. The brain uptake index of glutathione with and without an irreversible gamma-glutamyl transpeptidase inhibitor, acivicin, was similar. No significant differences in the regional uptake of labeled glutathione were found in rats pretreated with acivicin. The brain uptake index of tracer glutathione was similar to that of cysteine tracer and was lower than that of phenylalanine. The transport of oxidized glutathione (glutathione disfulfide) across the blood-brain barrier was not significantly different from that of sucrose, an impermeable marker. Brain radioactivity 15 s after carotid artery injection of labeled glutathione to rats pretreated with acivicin was predominantly in the form of glutathione. The in vivo glutathione uptake was saturable with an apparent Km of 5.84 mM. Amino acids, amino acid analogues, and other compounds [cysteine, phenylalanine, glutathione disulfide, gamma-glutamylglutamate, gamma-glutamyl p-nitroanilide, 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid (BCH)] did not affect glutathione transport. Our data suggest that glutathione is transported across the blood-brain barrier by a saturable and specific mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971830      PMCID: PMC296671          DOI: 10.1172/JCI114666

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Reduction of disulfide-containing amines amino acids, and small peptides.

Authors:  J Bulter; S P Spielberg; J D Schulman
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

2.  Glutathione metabolism at the blood-cerebrospinal fluid barrier.

Authors:  M E Anderson; M Underwood; R J Bridges; A Meister
Journal:  FASEB J       Date:  1989-11       Impact factor: 5.191

3.  Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection.

Authors:  W H Oldendorf
Journal:  Am J Physiol       Date:  1971-12

4.  A kinetic photometric method for serum gamma-glutamyl transpeptidase.

Authors:  G Szasz
Journal:  Clin Chem       Date:  1969-02       Impact factor: 8.327

5.  Kinetics of blood-brain transport of hexoses.

Authors:  W M Pardridge; W H Oldendorf
Journal:  Biochim Biophys Acta       Date:  1975-03-25

6.  Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione.

Authors:  P G Richman; A Meister
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

7.  Blood-brain barrier restriction of peptides and the low uptake of enkephalins.

Authors:  E M Cornford; L D Braun; P D Crane; W H Oldendorf
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

8.  Glutathione uptake and protection against oxidative injury in isolated kidney cells.

Authors:  T M Hagen; T Y Aw; D P Jones
Journal:  Kidney Int       Date:  1988-07       Impact factor: 10.612

9.  Glutathione turnover in the kidney; considerations relating to the gamma-glutamyl cycle and the transport of amino acids.

Authors:  R Sekura; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

10.  Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons.

Authors:  S P Raps; J C Lai; L Hertz; A J Cooper
Journal:  Brain Res       Date:  1989-07-31       Impact factor: 3.252

View more
  32 in total

1.  Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial.

Authors:  A Chiò; A Cucatto; A A Terreni; D Schiffer
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells.

Authors:  Gail D Zeevalk; Laura P Bernard; F T Guilford
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

3.  Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.

Authors:  Surendra P Singh; Vidhi Singh
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

Review 4.  Strategies to target drugs to gliomas and CNS metastases of solid tumors.

Authors:  B Milojkovic Kerklaan; O van Tellingen; A D R Huitema; J H Beijnen; W Boogerd; J H M Schellens; D Brandsma
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

5.  Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat.

Authors:  R Agarwal; G S Shukla
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

6.  In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes.

Authors:  Annika Lindqvist; Jaap Rip; Joan van Kregten; Pieter J Gaillard; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2015-08-15       Impact factor: 4.200

7.  Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.

Authors:  Ragy R Girgis; Seth Baker; Xiangling Mao; Roberto Gil; Daniel C Javitt; Joshua T Kantrowitz; Meng Gu; Daniel M Spielman; Najate Ojeil; Xiaoyan Xu; Anissa Abi-Dargham; Dikoma C Shungu; Lawrence S Kegeles
Journal:  Psychiatry Res       Date:  2019-03-12       Impact factor: 3.222

8.  Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease.

Authors:  G D Zeevalk; L Manzino; P K Sonsalla; L P Bernard
Journal:  Exp Neurol       Date:  2006-10-17       Impact factor: 5.330

Review 9.  The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.

Authors:  Nicholas Dopkins; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Immunology       Date:  2018-02-27       Impact factor: 7.397

10.  Expression cloning of a rat hepatic reduced glutathione transporter with canalicular characteristics.

Authors:  J R Yi; S Lu; J Fernandez-Checa; N Kaplowitz
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.